Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments

Autor: Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori

Publikováno v: Hematology Reports, Vol 15, Iss 1, Pp 57-65 (2023)

In recent years, new treatments have been studied for relapsed-refractory multiple myeloma (RRMM), including two CAR-T products and a variety of non-CAR-T agents. Since direct comparisons between these innovative treatments are not available, indirec

Externí odkaz: https://doaj.org/article/e66bd5262cf34d22a212584e1c223575

Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials

Autor: Marco Chiumente, Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Andrea Messori, Melania Rivano

Publikováno v: World Journal of Urology. 40:2609-2615

In recent years, new treatments have been approved for nonmetastatic castration-resistant prostate cancer (M0CRPC). Because direct comparisons between these treatments are not available to guide treatment decisions, indirect comparisons can be of int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509c1197754f87047dcfe0cedda80b7b
https://doi.org/10.1007/s00345-022-04143-8

The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis

Autor: Stefano Costantino, Daniele Mengato, Luca Cancanelli, Melania Rivano, Francesca Cammalleri, Roberta Rampazzo, Silvia Michielan, Laura Agnoletto, Marco Chiumente, Alessia Sartori, Federica Milani, Vera Damuzzo

Publikováno v: Neurology International
Neurology International; Volume 13; Issue 4; Pages: 682-694
Neurology International, Vol 13, Iss 65, Pp 682-694 (2021)

Health-related quality of life is frequently included in patient-reported outcomes aimed at evaluating the effectiveness of disease-modifying drugs for multiple sclerosis, but recent data about Italian patients are missing. A multicenter observationa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af573204cc8e174381538363ca3023c
http://europepmc.org/articles/PMC8706851

Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies

Autor: Daniele Mengato, Marco Chiumente, Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Andrea Messori

Publikováno v: Immunotherapy. 13:95-101

Background: The purpose of this study was to assess the effectiveness of immune checkpoint inhibitors (ICIs) in advanced urothelial carcinoma. Materials & methods: We selected seven cohorts of patients published in four clinical trials. The restricte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e6332fea1bfeba6b67e35886f0add1
https://doi.org/10.2217/imt-2020-0160

First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer

Autor: Marco Chiumente, Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Andrea Messori, Melania Rivano

Publikováno v: Immunotherapy. 14(11)

Background: In PD-L1-negative patients with advanced non-small-cell lung cancer (NSCLC), conclusive evidence in support of specific treatments remains lacking. Objectives: The efficacy of first-line chemoimmunotherapy versus chemotherapy alone was co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f28cba77e40592ad064c94a7c0647ef
https://pubmed.ncbi.nlm.nih.gov/35695029